Arzneiwerk AG VIDA (FRA: TLIK)

Market Cap	4.21M
Revenue (ttm)	59.68M
Net Income (ttm)	-2.20M
Shares Out	n/a
EPS (ttm)	-0.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.600 - 1.390
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2024

About Arzneiwerk AG VIDA

Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1996
• Employees: 39
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TLIK

Financial Performance

In 2023, Arzneiwerk AG VIDA's revenue was 59.28 million, a decrease of -19.21% compared to the previous year's 73.37 million. Losses were -2.88 million, -82.69% less than in 2022.